Table 3 Vessels/cardiac disorders following COVID-19 vaccines in Iran Blood involvement

1

Thrombotic thrombocytopenia

70

Female

Diabetes mellitus type 2, hypertension, and coronary artery disease

Not stated

ChAdOx1-S

1 day after the 1st dose

[20]

2

Vasculitis

55

Female

controlled sarcoidosis

Not stated

BBIBP–CorV

3 days after the 1st dose

[43]

3

Cerebral venous sinus thrombosis

55

Female

Hypertension/a surgery history of hysterectomy 10 years ago

Negative

ChAdOx1-S

After the 1st dose

[44]

4

Acquired thrombotic thrombocytopenic purpura (aTTP)

22

Female

–

Negative

ChAdOx1-S

3 weeks after the 1^st dose

[45]

5

Purpuric dermatosis &lymphocytic vasculopathy

53

Female

History of treated breast cancer

Not stated

BBIBP–CorV

9 days after the 1st dose

[46]

6

50

Male

–

Not stated

BBIBP–CorV

2 months after vaccination

[46]

7

Myocarditis

29

Male

–

Negative

Sputnik V

2 days after the 2nd dose

[47]

8

26

Male

–

Negative

ChAdOx1-S

4 days after the 2nd dose

[48]

9

32

Female

–

Negative

ChAdOx1-S

3 days after the 1st dose

[49]

10

Atrioventricular block

65

Male

–

Not stated

BBIBP–CorV

A few days after vaccination

[50]

11

Long QT interval and syncope

70

Male

Hypertension (HTN) and diabetes mellitus under medical treatment

Negative

ChAdOx1-S

3 days after the 1st

[51]